UBS Downgrades Eyebright Medical Technology (Beijing) to Neutral from Buy; Price Target is 40 Yuan
Eyebright Medical Technology (Beijing) (SHA:688050) has an average rating of overweight and mean price target of 55.33 yuan, according to analysts polled by FactSet. ( covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: )
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.